Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, is pleased to announce detailed results from the pivotal ...

After further evaluation, she was diagnosed with cholangiocarcinoma, or bile duct cancer, a rare and aggressive cancer that ...

Oddity Tech (NasdaqGM:ODD) recently reported a notable boost in shareholder returns, with its share price rising 67% over the past month. Key drivers behind this significant price movement include ...

Jazz Pharmaceuticals JAZZ will release its quarterly earnings report on Tuesday, 2025-05-06. Here's a brief overview for ...

Guardant Health exceeds Q1 expectations, boosts growth outlook, and gains from favorable pricing and approvals. Read more ...

NeoGenomics shares dropped 34% on April 29 after missing its Q1 revenue estimates. Check out why I view the stock price ...

Q1 2025 Earnings Call Transcript April 30, 2025 Guardant Health, Inc. beats earnings expectations. Reported EPS is $-0.49, ...

Guardant Health now expects full year 2025 revenue to be in the range of $880 to $890 million, representing growth of 19% to 20% compared to full year 2024. This compares to the prior range of $850 to ...

Ravindra Uppaluri, MD, PhD, discussed the KEYNOTE-689 trial, which investigated pembrolizumab in locally advanced head and ...

The FDA has approved a ready-to-dilute, multi-dose formulation of thiotepa (Tepylute) for use in breast and ovarian ...

FDA granted an accelerated approval for Vanrafia for the reduction of proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression. Vanrafia can be ...

LLY has delivered impressive returns of 15% year-to-date (as of April 30), outperforming the S&P 500’s 5% decline during the ...